HRT Financial’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

HRT Financial’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,981	Closed	-$527K	–	1860
2020 Q1	$527K	Buy	+10,981	New	+$511K	0.03%	376

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

HRT Financial's RARX Position: Q2 2020 in Review

HRT Financial sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 10,981 shares — an estimated $527K sold.

HRT Financial first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $527K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

HRT Financial reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
HRT Financial sold 10,981 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $527K.
HRT Financial first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
HRT Financial's Ra Pharmaceuticals, Inc. Common Stock position peaked at $527K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on HRT Financial's 13F filing for Q2 2020, filed 14 Aug 2020.